Using 18F-FDG PET/CT (FDG PET/CT) for systemic staging of patients with newly diagnosed stage III breast cancer may not be useful, according to a study presented at the American Roentgen Ray Society (ARRS) 2015 Annual Meeting in Toronto, Canada. {read more here}